RxDoctor Payments DataLook up a doctor →

Dawn Hansen, MD

Internal Medicine · Biloxi, MSNPI 1558323964

Payments from drug & device makers

$8,561in general payments, 2019–2025

Across 400 payments — averaging $21.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$761
  • UCB, Inc.$731
  • Johnson & Johnson$700
  • Sun Pharmaceutical Industries Inc.$503
  • Galderma Laboratories, L.p.$432
  • plus $4K from 22 others

What the payments were for

  • Food & beverage$8,04494%
  • Education$5176%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,561 in reported general payments places this provider in the 90th percentile of 846 internal medicine providers in Mississippi.

See all internal medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$1,038,413
Medicare patients
985
Services billed
10,895

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa19$411,686
Cosentyx Unoready PenSecukinumab13$118,815
Dupixent PenDupilumab27$101,980
Dupixent SyringeDupilumab20$74,566
Clobetasol Propionate128$5,798
Tacrolimus47$5,600
Ketoconazole127$2,972
Metronidazole45$2,956
Calcipotriene14$2,152
Tretinoin13$2,133
Fluorouracil17$1,391
Montelukast Sodium146$926
Clindamycin Phosphate29$843
Doxycycline Hyclate49$620
Imiquimod21$566

Paid to pharmacies, not to this prescriber.

Other internal medicine in Biloxi

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →